Anker Lundemose

Board member

Independent board member since 2010

Nationality: Danish

Age: 50

Serial biotech entrepreneur and co-founder of several biotech companies, including Symphogen A/S, Prosidion Ltd in the UK, and Santaris Pharma A/S. Currently Managing Partner at BioTesch.

Former managing director of OSI Pharmaceutical's venture arm in Zug, CH which has invested in several biotech companies including Danish Epitherapeutics A/S.

Mr Lundemose previously held positions at OSI Pharmaceuticals Inc, Prosidion Ltd, and Novo Nordisk and has served as member of the Board of Directors for Symphogen, Prosidion Ltd, OSI Pharmaceuticals UK Limited, OSI Investment Holding GmbH & OSI Investment Management GmbH, and for Display Biotech Systems.

Anker Lundemose is Chairman of the Board at InteRNA Technologies BV and board member at Adenium Biotech AS.

Mr Lundemose has experience within academia, executive management, large pharma, biotech, and business and corporate development. Has an international track record in R&D productivity, deal making, including execution of high-impact license agreements, and significant M&A transactions.

He is a Medical Doctor from the University of Aarhus, and holds a PhD in Molecular Microbiology and is Doctor of Medical Science (Dr.med.), both from the University of Aarhus.